ALSPW Spineway SAS

INTERNATIONAL MASTERCLASS

INTERNATIONAL MASTERCLASS

   

Spineway organizes an international masterclass

with expert spine surgeons

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its Spineway Academy department, with the support of 1

The event featured some 20 scientific papers and interactive round-table discussions led by opinion-leading surgeons who discussed their respective working practices and philosophies, and their experience with the prostheses used around the world and available in the various markets.

Over 60 French and international participants (USA, Mexico, Germany, UK, Spain, Luxembourg, Sweden, Switzerland, Thailand, India, Hong Kong, Australia) shared their experiences of disc replacement with cervical and lumbar disc prostheses.

Training at the Institut du Fer Moulin

On Monday September 11, Spineway Academy also held a training session on the implantation of its ESP prostheses at the .

It gave surgeons from Germany, Thailand and Malaysia the chance to train, practice and work under the guidance of expert surgeons in disc arthroplasty, and in that way to consolidate their practice. Spineway would like to extend particular thanks to the German surgeons who attended the event, and notes that Germany is a strategic market for its premium products such as ESP prostheses.

A department dedicated to scientific exchange and training for surgeons

The Spineway Academy department promotes scientific exchange and has the following main objectives:

  1. Strengthen scientific relations: by sharing experience between peers, encourage the transmission of information so that surgeons can develop their practice (diagnosis, indications, surgical procedure, evaluation and follow-up of results, publications) with the aim of improving post-operative outcomes/satisfaction for their patients.



  2. Organize training sessions: provide training in the use of instruments to support surgeons during their surgical procedures and anticipate the various surgical scenarios they may face so as to secure the procedure for the benefit of the patient.



Since the beginning of the year, the Spineway Academy has trained more than 220 French and international surgeons. These events help promote the visibility of Spineway products and serve to strengthen the Group’s reputation across its various geographies.

Next events:

September 19, 2023 – H1 2023 results

October 4 to 6, 2023 – Eurospine meeting in Frankfurt

October 12, 2023 – Q1 2023 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.

Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).

ISIN: FR001400BVK2 - ALSPW        

Contacts:





SPINEWAY



Shareholder-services line



Available Tuesday through Thursday



+33 (0)806 706 060




Eligible PEA / PME





ALSPW





Euronext Growth





AELIUM



Finance & Communication



Investor relations



Solène Kennis






1 A learned society whose purpose is to organize scientific conferences, publish scientific works, evaluate clinical results and provide medical training.

 

Attachment



EN
14/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE

Spineway : 2025 annual results

Spineway : 2025 annual results Ecully, February 17, 2026 – 7:00 p.m. SPINEWAY2025 annual results Revenue up 4%Improved resultsStronger growth potential Condensed consolidated income statement20252024Pro forma* 2024ReportedIn thousands of euros Revenue12,43011,950 11,950Cost of sales-3,783-3,699 -3,699Gross margin 8,6478,250 8,250% of revenue69,6%69,0% 69%Net operating expenses-10,780-10,227 -9,131Of which external expenses-3,967-3,522 -3,646Of which personnel expenses-4,600-4,890 -4,890     Of which other op. income and expenses-1,436-920 -358Of which dep., amort., and provisions-777-895 ...

 PRESS RELEASE

SPINEWAY : Résultats annuels 2025

SPINEWAY : Résultats annuels 2025 Ecully, le 17 février 2026 – 18h30 SPINEWAY Résultats annuels 2025 Un chiffre d’affaires en progression de + 4%Une amélioration des résultatsUn potentiel de croissance renforcé Compte de résultat consolidé résumé20252024Proforma* 2024PubliéEn milliers d'euros Chiffre d'affaires12 43011 950 11 950Coût des ventes-3 783-3 699 -3 699Marge brute8 6478 250 8 250% du CA69,6%69,0% 69%Coûts nets d’exploitation-10 780-10 227 -9 131Dont charges externes-3 967-3 522 -3 646Dont charges de personnel-4 600-4 890 -4 890     Dont autres pdts et ch. d'exploitation-1 43...

 PRESS RELEASE

SPINEWAY : Chiffre d’affaires annuel 2025 de 12,4 ME avec une accéléra...

SPINEWAY : Chiffre d’affaires annuel 2025 de 12,4 ME avec une accélération des ventes au T4 2025 (+34%) Ecully, le 13 janvier 2026 – 18h30 SPINEWAY Chiffre d’affaires annuel 2025 de 12,4 M€ avec une accélération des ventes au T4 2025 (+34%) En milliers d’euros20252024Variation en %CA 1er semestre5 5736 535- 15%CA 2ème semestre6 8575 415+ 27%CA annuel12 43011 950+ 4% Données consolidées non auditées Au dernier trimestre 2025, Spineway, spécialiste des implants innovants pour le traitement des pathologies de la colonne vertébrale (rachis), a bénéficié d’une accélération des ventes sur l...

 PRESS RELEASE

SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sal...

SPINEWAY : 2025 revenue of €12.4 million,  with an acceleration of sales in Q4 2025 (+34%) Ecully, January 13, 2026 – 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2 revenue6,8575,415+27%Full-year revenue12,43011,950+4% Unaudited consolidated data In the final quarter of 2025, Spineway, a specialist in innovative implants for the treatment of severe spine disorders, benefited from an acceleration in sales across all of its markets and the receipt of key account orders d...

 PRESS RELEASE

SPINEWAY : Evolution Surgical distribuera les prothèses discales CP-ES...

SPINEWAY : Evolution Surgical distribuera les prothèses discales CP-ESP et LP-ESP en Australie  Ecully, le 22 octobre 2025 – 8h30 SPINEWAY Evolution Surgical distribuera les prothèses discales CP-ESP et LP-ESP de Spineway en Australie  Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), annonce la conclusion d'un accord avec Evolution Surgical, pour la distribution exclusive de ses prothèses discales ESP en Australie à partir du 25 octobre 2025. Orthotech, l’ancien distributeur sur cette zone, assurera en collaboratio...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch